VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

189 hedge funds and large institutions have $389M invested in Vanda Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 52 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+12
Holders Change %
+6.78%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
76
Reduced
52
Closed
16
Calls
$354K
Puts
$420K
Net Calls
-$66K
Net Calls Change
-$717K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$13.2M
2
BlackRock
2
BlackRock
New York
$76.3M
3
Citadel Advisors
3
Citadel Advisors
Florida
$4.05M
4
BCM
4
Bridgeway Capital Management
Texas
$2.41M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$5.94M

Top Sellers

1
Macquarie Group
1
Macquarie Group
Australia
$9.78M
2
EIP
2
Epoch Investment Partners
New York
$10.3M
3
PAI
3
Palo Alto Investors
California
$8.04M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$4.23M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$21.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$76.3M +$3.92M +529,981 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$29.5M +$721K +97,612 +3%
State Street
3
State Street
Massachusetts
$27.5M +$314K +42,447 +1%
Renaissance Technologies
4
Renaissance Technologies
New York
$21.4M -$3M -405,808 -12%
Millennium Management
5
Millennium Management
New York
$13.2M +$12.1M +1,633,788 +1,090%
Assenagon Asset Management
6
Assenagon Asset Management
Luxembourg
$11.7M -$15.8K -2,143 -0.1%
Goldman Sachs
7
Goldman Sachs
New York
$11M -$1.58M -213,680 -13%
EIP
8
Epoch Investment Partners
New York
$10.3M -$9.81M -1,326,875 -49%
Macquarie Group
9
Macquarie Group
Australia
$9.78M -$11.9M -1,604,995 -55%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$8.1M +$1.43M +193,006 +21%
PAI
11
Palo Alto Investors
California
$8.04M -$7.97M -1,078,549 -50%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$7.78M +$193K +26,077 +3%
Hotchkis & Wiley Capital Management
13
Hotchkis & Wiley Capital Management
California
$7.21M +$267K +36,070 +4%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$6.28M -$41.6K -5,625 -0.7%
Ameriprise
15
Ameriprise
Minnesota
$6.22M -$518K -70,172 -8%
Federated Hermes
16
Federated Hermes
Pennsylvania
$5.94M +$2.29M +310,073 +63%
Prudential Financial
17
Prudential Financial
New Jersey
$5.88M +$849K +114,930 +17%
Morgan Stanley
18
Morgan Stanley
New York
$5.79M +$2.18M +294,678 +60%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$5.3M +$609K +82,443 +13%
Charles Schwab
20
Charles Schwab
California
$4.91M +$149K +20,179 +3%
Northern Trust
21
Northern Trust
Illinois
$4.33M -$63.3K -8,567 -1%
Nuveen Asset Management
22
Nuveen Asset Management
Illinois
$4.23M -$3.74M -506,276 -47%
Citadel Advisors
23
Citadel Advisors
Florida
$4.05M +$3.4M +460,594 +525%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$3.74M -$1.91M -258,012 -34%
PAMS
25
Pictet Asset Management (Switzerland)
Switzerland
$3.37M +$840K +113,627 +33%
1
2 3 4 5